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$38,700 for CRHD. Total annual hospitalization charges
for ARF and CRHD were estimated at $1.9 billion in year
2002 US dollars. CONCLUSIONS: Rheumatic fever 
and its sequelae CRHD represent a signiﬁcant economic
burden in the US. Total annual hospitalization charges
estimated for ARF and CRHD are substantially higher
than the recent estimate by the Institute of Medicine (Vac-
cines for the 21st Century, A Tool for Decisionmaking,
2000) for all group A streptococcus-associated hospital-
izations (<$100 million).
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OBJECTIVES: Our objective is to demonstrate software
technology that predicts the toll of smoking and deter-
mines the return on investment (ROI) of tobacco control
programs in a managed care setting. METHODS: We
developed a software application that incorporates a
Markov model to track changes in smoking status in 
6-month cycles over 20 years. Important features of a
managed care setting such as member turnover and plan
beneﬁt design are incorporated in the model. A curvi-
linear function of quit duration was used to estimate
disease risk for former smokers. The model predicts all
medical costs associated with a given population by esti-
mating costs for 39 conditions, 17 of which are smoking
related. It calculates case rates and cost per case by
smoking status for each condition using epidemiological
concepts of relative risk and smoking-attributable frac-
tion. Additionally, non-medical costs associated with
smoking are estimated from the employer and societal
perspectives. RESULTS: The smoking prevalence in a
commercially insured health plan of 980,292 members is
predicted to increase to 21% in year 2022 from 16% in
2002, if there is no change in smoking behavior. Current
smokers are predicted to contribute 36% of the medical
costs of smoking related conditions at year 2002 and
increase their share to 44% in 2022. Relative to all
medical costs, this is equivalent to 19% in 2002 and 28%
in 2022. The incremental non-medical costs per current
smoker employee are estimated to be $2047 in 2002.
CONCLUSIONS: MediSave Smoking Cessation enables
rapid prediction of the baseline tobacco burden on
medical as well as non-medical costs in a managed care
context, and permits estimation of the ROI of interven-
tion programs. Its user-friendly format facilitates sensi-
tivity analyses of various program characteristics. As
such, it is a useful tool to build the business case for
tobacco control programs.
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OBJECTIVES: Our objective is to estimate the medical
and non-medical savings associated with two smoking
cessation interventions in a Minnesota health plan using
a new predictive technology, and to determine the return
on investment (ROI). METHODS: We developed a
Markov model to simulate the smoking behaviors, health
outcomes and impact of tobacco control programs in a
managed care setting. We integrated the model into a soft-
ware application called MediSave and used it to deter-
mine the combined impact of two interventions, which
include coverage of smoking cessation pharmaceutical
aids (such as buproprion or nicotine substitutes) and
physician advice. Program participation and cost data
were provided by the health plan. Intervention quit rates
were derived from literature. Medical savings result from
the higher quit rate associated with the interventions.
Non-medical savings accrue to the employer because of
reduction in smoking breaks as well as illness days. The
ROI is calculated as the net (medical and non-medical)
savings over program costs. RESULTS: In a commercially
insured population of 980,292 members, the combined
interventions generate positive net savings of $0.02 per
member per month (PMPM) at the end of ﬁrst year. They
generate gross savings of $0.17 PMPM, only 33% of
which are from medical savings. First year ROI is esti-
mated to be 16% and predicted to increase signiﬁcantly
over the next 20 years. Eliminating non-medical savings
from the analysis will result in a negative ROI in the ﬁrst
year but will not affect the positive net savings past year
5. CONCLUSIONS: MediSave Smoking Cessation is an
effective tool in making the business case for tobacco
control programs. In our study, the combined impact of
pharmaceuticals and physician advice is cost-beneﬁcial.
The interventions produce substantial non-medical
savings in the short term and generate signiﬁcant medical
savings in the long term.
CARDIOVASCULAR DISEASES/DISORDERS—
Quality of Life/Preference Based Outcomes
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OBJECTIVE: Two relatively common myths regarding
the impact of obesity on quality of life are: 1) women are
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affected more than men; and 2) QOL impacts of obesity
decline with age. Qualitative work during the develop-
ment of the Obesity and Weight Loss Quality-of-Life
Measure (OWLQOL) indicated that these assumptions
may not necessarily be completely valid. We explore 
the degree to which weight-related quality of life varies
between gender and across age groups. METHODS:
Through Knowledge Networks, a web-based TV survey
panel similar to the national population, an adult sample
(age > 20) of 1342 obese persons (BMI >= 30) was
prospectively and randomly selected. Quality of life was
measured by the total summary score and four subdo-
main scores of the OWLQOL. QOL scores were plotted
by age and gender. Analysis of variance was used to
examine the signiﬁcance of the differences between group
means. RESULTS: The greatest disparities in QOL scores
by gender appear in the younger (20–35) age group where
the mean OWLQOL score for males was 82.7, and only
58.4 for females (F = 75.6; P < 0.001). The smallest
gender differences between mean scores was demon-
strated in the oldest (66+) group (87.3 for males and 77.7
for females (F = 11.5; P = 0.001)). When assessing QOL
scores separately by gender, the differences between age
groups are only signiﬁcant within the female group (P <
0.01). CONCLUSIONS: The signiﬁcant differences in
weight-related quality of life (24.3 point difference in the
younger group and 9.6 for the oldest group) tend to be
masked when looking only at combined group totals. Evi-
dence from this data suggests that women are affected dif-
ferently by obesity than men (but more so in the younger
age groups) and that negative QOL impacts from obesity
do lessen with age, but these differences are only signiﬁ-
cantly different for female populations.
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OBJECTIVE: Adults who are overweight or obese are at
greater risk for other serious health conditions and self-
report a variety of negative impacts on quality of life,
including low self-esteem, social stigma and many both-
ersome physical symptoms. This analysis explores the
relationship between symptoms and physically linked
quality-of-life scores with comparisons made between
BMI levels. METHODS: Through Knowledge Networks,
a web-based TV survey panel similar to the national pop-
ulation, an adult sample of 1348 obese persons (BMI 30
or higher) and 1157 persons (BMI less than 30) were
prospectively and randomly selected. Using the newly
developed Weight-Related Symptom Measure (WRSM),
we obtained self-reported data for a list of 20 physical
symptoms. Quality of life was measured by the Obesity
and Weight Loss Quality of Life Measure (OWLQOL).
For each symptom, we identiﬁed the differences in the
physical health subscale of the OWLQOL for those re-
porting and not reporting the symptom and then com-
pared those results between BMI groups. RESULTS: For
all symptoms, there was a signiﬁcant difference in scores
on the physical health subscale of the OWLQOL between
those who reported the symptom (55.9 to 89.7) and those
who did not (73.8 to 95.9), indicating higher quality of
life for those not reporting symptoms. Those reporting
each symptom demonstrated highly signiﬁcant differences
between high (55.9 to 69.2) and low BMI groups (82.5
to 89.7) for physical health related QOL, indicating
higher QOL for those with lower BMI levels. CONCLU-
SIONS: While the physical symptoms that occur fre-
quently in obese populations can also be experienced by
those with low BMI scores, there is a far greater tendency
for them to be reported in individuals with BMI scores
greater than 30, and a signiﬁcantly greater negative
impact of these same symptoms on the QOL of those who
have BMI scores of 30 or more.
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OBJECTIVE: To describe perceived work performance of
patients with the diagnosis of acute coronary syndrome
(ACS) and to determine predictive relationships of several
patient-speciﬁc independent variables. METHODS: All
ACS patients discharged from a university afﬁliated hos-
pital during a 3-year period were mailed a questionnaire
that included the Work Performance Scale (WPS). Inde-
pendent variables included the SF-8 (PCS-8, MCS-8), 
the EQ-5D General Health Visual Analog Scale (VAS),
cardiac functional status [Duke Activity Status Index
(DASI)], symptom count (Symptom Distress Checklist),
comorbidity index (Charlson self-administered), patient-
perceived cardiac disease severity, medication count, 
compliance score, job satisfaction, current employment
duration, patient demographics, and ACS type [unstable
angina (UA) or myocardial infarction (MI)]. This analy-
sis includes respondents who indicated current employ-
ment. Stepwise-elimination (p < 0.05) linear regression
models determined the combined predictive ability of
independent variables on WPS. Due to the high correla-
tion between the PCS-8, VAS, and DASI, three separate
models were used with each one as a predictor variable.
RESULTS: To date, 414 of 1230 patients (34%) have
responded, including 122 (29.5%) currently working.
Current workers averaged 57.6(±8.6) years of age; 80.3%
male; 94.3% Caucasian; 69.2% history of MI; 13.4%
severe or worse perceived cardiac disease severity.
Respondents reported the following mean(s.d.) responses:
DASI 26.0(±7.4); comorbidity index 1.7(±1.4); medica-
